SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0000950109-03-002084
Filing Date
2003-04-10
Accepted
2003-04-10 14:03:52
Documents
16

Document Format Files

Seq Description Document Type Size
1 FILED PURSUANT TO RULE 425 d425.htm 425 44330
3 GRAPHIC g55727bar.jpg GRAPHIC 7885
4 GRAPHIC g55727boder.jpg GRAPHIC 143241
5 GRAPHIC g55727boder02.jpg GRAPHIC 12311
6 GRAPHIC g55727cov_rule.jpg GRAPHIC 6196
7 GRAPHIC g55727diamond.jpg GRAPHIC 2855
8 GRAPHIC g55727footer_number01.jpg GRAPHIC 693
9 GRAPHIC g55727footer_number02.jpg GRAPHIC 917
10 GRAPHIC g55727footer_number03.jpg GRAPHIC 713
11 GRAPHIC g55727footer_number04.jpg GRAPHIC 917
12 GRAPHIC g55727integration_team.jpg GRAPHIC 29122
13 GRAPHIC g55727notebook.jpg GRAPHIC 14404
14 GRAPHIC g55727npslogo.jpg GRAPHIC 17925
15 GRAPHIC g55727photo.jpg GRAPHIC 3005
16 GRAPHIC g55727sig01.jpg GRAPHIC 4635
17 GRAPHIC g55727sig02.jpg GRAPHIC 3449
  Complete submission text file 0000950109-03-002084.txt   296187
Mailing Address
Business Address 420 CHIPETA WAY STE 240 SALT LAKE CITY UT 84108-1256 8015834939
NPS PHARMACEUTICALS INC (Filed by) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address 420 CHIPETA WAY STE 240 SALT LAKE CITY UT 84108-1256 8015834939
NPS PHARMACEUTICALS INC (Subject) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 000-23272 | Film No.: 03645257
SIC: 2836 Biological Products, (No Diagnostic Substances)